Richard Pzena Pfizer Inc Transaction History

Pzena Investment Management LLC

$28.8 Billion
Q1 2024

A detailed history of Richard Pzena (Pzena Investment Management LLC) transactions in Pfizer Inc stock. As of the latest transaction made, Pzena Investment Management LLC holds 7,670,445 shares of PFE stock, worth $215 Million. This represents 0.74% of its overall portfolio holdings.

Number of Shares

7,670,445

Previous 2,723,445 181.64%

Holding current value

$215 Million

Previous $78.4 Million 171.47%

% of portfolio

0.74%

Previous 0.3%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 03, 2024	BUY	$25.89 - $29.73 $128 Million - $147 Million	4,947,000 Added 181.64%	7,670,445 $213 Million
Q4 2023 Feb 09, 2024	BUY	$26.13 - $33.94 $112,750 - $146,451	4,315 Added 0.16%	2,723,445 $78.4 Million
Q3 2023 Nov 09, 2023	SELL	$32.09 - $37.51 $175,885 - $205,592	-5,481 Reduced 0.2%	2,719,130 $90.2 Million
Q2 2023 Aug 04, 2023	SELL	$36.12 - $41.79 $622,636 - $720,376	-17,238 Reduced 0.63%	2,724,611 $99.9 Million
Q1 2023 May 12, 2023	SELL	$39.39 - $51.28 $708,389 - $922,219	-17,984 Reduced 0.65%	2,741,849 $112 Million

Q4 2022 Feb 03, 2023	SELL	$41.75 - $54.5 $4.57 Million - $5.97 Million	-109,519 Reduced 3.82%	2,759,833 $141 Million
Q3 2022 Nov 04, 2022	SELL	$43.76 - $53.42 $4.38 Million - $5.35 Million	-100,083 Reduced 3.37%	2,869,352 $126 Million
Q2 2022 Aug 05, 2022	SELL	$46.53 - $55.17 $19.9 Million - $23.6 Million	-427,993 Reduced 12.6%	2,969,435 $156 Million
Q1 2022 May 06, 2022	SELL	$45.75 - $56.69 $73 Million - $90.5 Million	-1,595,690 Reduced 31.96%	3,397,428 $176 Million
Q4 2021 Feb 04, 2022	SELL	$41.32 - $61.25 $1.19 Million - $1.76 Million	-28,776 Reduced 0.57%	4,993,118 $295 Million
Q3 2021 Nov 05, 2021	BUY	$39.25 - $50.42 $78.6 Million - $101 Million	2,003,764 Added 66.39%	5,021,894 $216 Million
Q2 2021 Aug 06, 2021	BUY	$35.91 - $40.68 $4.27 Million - $4.84 Million	118,931 Added 4.1%	3,018,130 $118 Million
Q1 2021 May 07, 2021	BUY	$33.49 - $37.77 $2.98 Million - $3.36 Million	89,086 Added 3.17%	2,899,199 $105 Million
Q4 2020 Feb 05, 2021	BUY	$33.47 - $42.56 $2.48 Million - $3.16 Million	74,178 Added 2.71%	2,810,113 $103 Million
Q3 2020 Oct 30, 2020	BUY	$31.75 - $37.25 $9.86 Million - $11.6 Million	310,417 Added 12.8%	2,735,935 $100 Million
Q2 2020 Jul 31, 2020	SELL	$30.12 - $36.54 $21.8 Million - $26.4 Million	-722,584 Reduced 22.95%	2,425,518 $79.3 Million
Q1 2020 May 01, 2020	SELL	$27.03 - $38.62 $9,190 - $13,130	-340 Reduced 0.01%	3,148,102 $103 Million
Q4 2019 Feb 07, 2020	BUY	$32.92 - $37.36 $10,303 - $11,693	313 Added 0.01%	3,148,442 $123 Million
Q3 2019 Nov 01, 2019	SELL	$32.49 - $42.13 $188,929 - $244,985	-5,815 Reduced 0.18%	3,148,129 $113 Million
Q2 2019 Aug 02, 2019	SELL	$36.98 - $41.52 $1.45 Million - $1.63 Million	-39,262 Reduced 1.23%	3,153,944 $137 Million
Q1 2019 May 03, 2019	SELL	$37.5 - $41.2 $18.9 Million - $20.7 Million	-502,831 Reduced 13.6%	3,193,206 $136 Million
Q4 2018 Feb 08, 2019	SELL	$38.47 - $43.86 $28.6 Million - $32.6 Million	-742,393 Reduced 16.73%	3,696,037 $161 Million
Q3 2018 Nov 09, 2018	SELL	$34.47 - $41.81 $628,629 - $762,488	-18,237 Reduced 0.41%	4,438,430 $196 Million
Q2 2018 Aug 03, 2018	BUY	$32.98 - $35.16 $2.94 Million - $3.14 Million	89,174 Added 2.04%	4,456,667 $162 Million
Q1 2018 May 04, 2018	BUY	$31.91 - $37.02 $202,628 - $235,077	6,350 Added 0.15%	4,367,493 $155 Million
Q4 2017 Feb 09, 2018	BUY	$33.26 - $35.29 $11.7 Million - $12.5 Million	352,869 Added 8.8%	4,361,143 $158 Million
Q3 2017 Nov 03, 2017	BUY	$31.0 - $34.15 $124 Million - $137 Million	4,008,274	4,008,274 $143 Million

Others Institutions Holding PFE

# of Institutions

3,159

Shares Held

3.68B

Call Options Held

67.4M

Put Options Held

113M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $157B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track Richard Pzena's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Pzena Investment Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pzena Investment Management LLC and Richard Pzena with notifications on news.

Account